Comparison of knee osteoarthritis treatment in the non-obese vs obese populations across different medical specialties  by Forrester, K. et al.
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A202during the post OAHKS implementation period indicated that OAHKS
patients waited a shorter time for their initial appointment (median:
63 versus 93 days, p<0.01) and once consented for surgery, OAHKS
patients waited a shorter time for their procedure (median 141 versus
218 days, p<0.01).
Interview data demonstrated that patients reported high levels of
satisfaction with the OAKHS particularly related to the education
provided regarding their condition and optimisation of non operative
management. There was consensus amongst clinicians that the OAHKS
is a valuable service which facilitates timely access to intervention and
minimises inappropriate surgical referrals. Project team members
identiﬁed orthopaedic surgeon engagement was critical to the serv-
ice’s success. They were highly satisﬁed the project had been imple-
mented as initially planned. Inclusion of experienced clinicians,
academics, and hospital management and government representatives
facilitated the development of a comprehensive and sustainable model
of care.
Conclusions: Implementation of the OAHKS at RMH has improved
access to care for patients with hip and knee osteoarthritis through
reduction of key wait times. Qualitative data indicate that patients and
clinicians are highly satisﬁed with this model of care and highlights
potential reasons for its success/sustainability.
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COMPARISON OF TOTAL KNEE REPLACEMENT COSTS BETWEEN 2005
AND 2010
K. Wang. Peking Univ. People's Hosp., Beijing, China
Purpose: To analyse changes in hospitalization costs for total knee
replacement(TKR) during 5 years by comparing those of 2005 and 2010,
evaluate the role of clinical pathway in controlling hospitalization cost
and to provide the basis for reasonable control of medical cost.
Methods: We retrospectively analyzed the data of patients undergoing
unilateral and bilateral total knee replacement in 2005 and 2010 in
Peking University People's Hospital.There were 72 unilateral and 92
bilateral total knee replacement cases in 2005, whereas the number of
those in 2010 was 265 and 206 respectively. All charges were assigned
to 1 of 9 categories: hospital room, nursing, radiology and laboratory,
prosthesis, blood transfusion, surgery, pharmacy, treatment, diagnosis.
We compared the total costs and cost of each category between 2005
and 2010.
Results: There was no statistical signiﬁcant difference between 2005
and 2010 in terms of age, gender distribution, primary disease and
type of prosthesis. The total costs for unilateral and bilateral TKR was
8173.25 dollar and 14257.64 dollar in 2010, respectively. They were
both signiﬁcantly lower than those of 2005(9007.98 dollar and
14962.18 dollar respectively). The charge for each category of TKR in
2010 was 91.81, 23.72, 506.96, 384.4, 302.82, 804.84, 25.25, 869.72, and
6878.1 dollar. Compared with 2005, Each category of charge dropped
in 2010, especially the cost of surgery, diagnosis and hospital room,
which decreased by 55.41%, 33.45%, 37.33% respectively. The tendency
of change in charge of unilateral and bilateral TKR was similar to the
overall costs.
Conclusions: The total costs for TKR in 2010 were lower than those of
2005, which might be the result of adopting Clinical Pathway(CP) since
2010. Nevertheless, the prosthesis cost accounted for a large proportion
in both years. Therefore, controlling the prosthesis cost is an effective
way to reduce medical costs for TKR.
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COMPARISON OF KNEE OSTEOARTHRITIS TREATMENT IN THE NON-
OBESE VS OBESE POPULATIONS ACROSS DIFFERENT MEDICAL
SPECIALTIES
K. Forrester, F. Tauﬁq, J. Samuels. NYU Langone Hosp. for Joint Diseases,
New York, NY, USA
Purpose: Knee osteoarthritis (KOA) in the obese population is
under-diagnosed and often under-treated when identiﬁed. Providersoften attribute knee pain to excess weight without considering
articular pathology, and they are less likely to believe that obese
patients will comply with treatment recommendations. The liter-
ature to date does not specify if patients in different BMI/obesity
subgroups (non-obese vs obese, BMI 29.9 kg/m2 vs 30 kg/m2) are
offered or suggested the same treatment options for their KOA pain.
Here we look retrospectively at the approaches to KOA treatment
across the 2 BMI subgroups, with respect to use of acetaminophen,
non-steroidal anti-inﬂammatory drugs (NSAIDs)/COX-2 inhibitors,
physical therapy, intra-articular steroid injections, and intra-articu-
lar hyaluronic acid (HA) injections. We also compare the approaches
to treatment of KOA in obesity between the ﬁve physician specialties
of rheumatology, orthopedics, sports medicine, physiatry, and
internal medicine.
Methods: We conducted a search of the electronic medical record
between January 1 and December 31, 2013 for patients seen by the 5
physician specialties at New York University Langone Medical Center.
The study selected patients with ICD-9 codes for “knee osteoarthritis,”
“osteoarthritis,” and “knee pain.” From the resulting list of 4,486
patients, we have reviewed the ﬁrst 750 charts and selected for clinical
and radiographic KOA while excluding patients with bilateral knee
replacements, trauma within 6 weeks, or concurrent rheumatoid
arthritis, psoriatic arthritis, gout, pseudogout, or bursitis. From this
initial cohort of 750 we found 105 whomet criteria (25 patients seen by
rheumatologists, 26 by orthopedists, 28 by sports medicine, 12 by
physiatrists, and 14 by internists). After recording BMIs, demographics,
comorbidities, KOA characteristics, and KOA management, we analyzed
patterns of the 5 types of treatment for the 2 BMI subgroups, and by
physician specialty.
Results: The preliminary cohort of 105 patients had an overall mean
BMI of 30.6 ±7.1 and mean age of 62.3 ±14.3 years with 85.6%
females. We identiﬁed 51 non-obese patients with BMI <30 and 54
obese patients with a BMI 30. We found some differences between
the BMI-stratiﬁed treatment patterns when including all specialists
together. Physicians overall were more likely to offer HA injections to
non-obese patients than to obese patients (69.4% vs. 26.7%) - but
conversely administered intra-articular steroid injections to obese
patients more often than to non-obese patients (47% vs. 14%).
Physicians did not treat the BMI subgroups differently with regards
to acetaminophen use, NSAID use, or physical therapy referral.
Rheumatologists prescribed more NSAIDs/ COX-2 inhibitors to non-
obese patients than to those with a BMI 30 (64% vs 40%). Internal
medicine physicians prescribed more acetaminophen to non-obese
patients (57% vs 33%), but there was no difference in the other
specialties. Multiple specialties prescribed more HA viscosupple-
mentation injections to non-obese patients compared to obese,
including rheumatology (35% vs 13%), orthopedics (33% vs 15%), and
internal medicine physicians (33% vs 0%). All specialties prescribed
intra-articular steroid injections to obese patients more often than
non-obese patients (47% vs 14%). Rheumatologists and sports medi-
cine physicians referred more patients in general to physical therapy
(74% and 96%) compared to orthopedists, physiatrists, and internal
medicine physicians (62%, 60%, and 62%, respectively). Additionally,
rheumatologists prescribed more acetaminophen and NSAIDs than
the other specialties combined (52% vs 14% and 56% vs 46%,
respectively).
Conclusions: Our pilot data suggests a difference in KOA treatment
between non-obese and obese patients, and often between physi-
cian specialties. Obese pateints are more likely to receive steroid
injections but less likely to receive HA injections were recom-
mended less often to obese patients than to non-obese patients.
Rheumatologists more often prescribe non-invasive treatments
compared to orthopedists, physiatrists, and internal medicine
physicians, while we found that sports medicine physicians refer
more patients to physical therapy. Identiﬁcation of these divergent
KOA treatment patterns of obese patients as well as between spe-
cialists warrants discussion to optimize algorithms across muscu-
loskeletal care.
